Influence of NUDT15 Genotyping on Dose Intensity of Thiopurine Administration and Long-Term Clinical Outcomes

    Shotaro Tsunoda, Yuichiro Kojima, Yosuke Hirotsu, Hiroyuki Amano, Yuko Miura, Hiroshi Ashizawa, Hiroshi Ohyama, Kei Hosoda, Yoshio Suzuki, Hitoshi Mochizuki, Shin Maeda, Masao Omata
    Image

    Preprint — not peer reviewed. This was posted to a preprint server or data repository. It has not been through a journal's review process, and its findings may change or not hold up.

    Studysummary This study found that among patients with inflammatory bowel disease, those with the NUDT15 mutation had a reduced tolerance for thiopurine dosage over the long term and were more likely to require hospitalization and surgery compared to those without the mutation.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →